ファースト・トラックス・バイオセラピューティクス
First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.94 | $0 | -$32M |
| 2026 Q1 | -1.45 | $0 | -$33M |
| 2025 Q1 | -1.36 | $0 | -$45M |